Universal Immunization Program in India

Year : 2024 | Volume : | : | Page : –
By

Lakshay Bhutani,

  1. Student Department of Life science, Amity University, Noida Uttar Pradesh India

Abstract

The Universal Immunization Program (UIP) in India, initiated by the Government of India in 1985 and incorporated into the Child Survival and Safe Motherhood Program in 1992, plays a crucial role in enhancing public health through systematic vaccination efforts. This program aims to save lives and strengthen immune systems by administering vaccines and antibiotics. The UIP has spurred the development of various campaigns, including mass media efforts, to promote immunization against a range of diseases such as tetanus, coronavirus, and others. Supported by the Bureau of Energy and Family Prosperity, the Management of India, and the National Technical Advisory Group on Immunization (NTAGI), the UIP provides essential vaccines to infants, children, and pregnant women. India, as a major vaccine manufacturing hub with a robust national regulatory authority, is integral to the global supply of vaccines and conducts one of the world’s largest immunization programs. In recent advancements, the UIP has introduced adult vaccines against specific diseases like the orient type of encephalitis in areas with high incidence rates, following thorough studies and consultations with NTAGI. Vaccines under UIP can be categorized into two types: inactivated and live-attenuated. Inactivated vaccines use dead pathogens to stimulate immunity and require frequent booster shots, examples include polio and rabies vaccines. Live-attenuated vaccines, on the other hand, use weakened forms of pathogens to induce a strong, lasting immune response, as seen in vaccines for measles, mumps, rotavirus, smallpox, and chickenpox. The development of vaccines generally involves either inactivating the virus chemically or physically, or weakening it before administration. Although inactivated vaccines necessitate regular transfusions to maintain immunity, they are a critical component of the immunization strategy. Through these multifaceted efforts, the UIP continues to combat infectious diseases and safeguard public health in India.

Keywords: Electronic Vaccine, Hepatitis-B, Rotavirus Vaccine, Cold Chain, Immunization

How to cite this article: Lakshay Bhutani. Universal Immunization Program in India. Research & Reviews: A Journal of Microbiology & Virology. 2024; ():-.
How to cite this URL: Lakshay Bhutani. Universal Immunization Program in India. Research & Reviews: A Journal of Microbiology & Virology. 2024; ():-. Available from: https://journals.stmjournals.com/rrjomv/article=2024/view=156794

References

  1. Pneumococcal Conjugate Vaccine Introduction in India�s Universal Immunization Program [Internet]. Indianpediatrics.net. 2017. Available from: https://www.indianpediatrics.net/june2017/june-445-446.htm#:~:text=By%20making%20it%20available%20under,%2C%20Himachal%20Pradesh%20%5B1%5D.
  2. Anekwe TD, Kumar S. The effect of a vaccination program on child anthropometry: evidence from India’s Universal Immunization Program. Journal of Public Health. 2012 Dec 1;34(4):489-97.
  3. Pradhan SK. Time to revamp the universal immunization program in India. Indian Journal of Public Health. 2010 Apr 1;54(2):71-4.
  4. Shrivastwa N, Gillespie BW, Lepkowski JM, Boulton ML. Vaccination timeliness in children under India’s universal immunization program. The Pediatric Infectious Disease Journal. 2016 Sep 1;35(9):955-60.
  5. Kim D, Pekgün P, Yildirim İ, Keskinocak P. Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach. Vaccine. 2021 Nov 16;39(47):6876-82.
  6. Có-Rives I, Chen AY, Moore AC. Skin-Based Vaccination: A Systematic Mapping Review of the Types of Vaccines and Methods Used and Immunity and Protection Elicited in Pigs. Vaccines. 2023 Feb 16;11(2):450.
  7. Shen AK, Fields R, McQuestion M. The future of routine immunization in the developing world: challenges and opportunities. Global Health: Science and Practice. 2014 Dec 1;2(4):381-94.
  8. Dinleyici EC, Borrow R, Safadi MA, van Damme P, Munoz FM. Vaccines and routine immunization strategies during the COVID-19 pandemic. Human vaccines & immunotherapeutics. 2021 Feb 1;17(2):400-7.
  9. Anderson R, Perrier T, Pervaiz F, Sisouveth N, Kumar B, Phongphila S, Rahman A, Dhiman R, Newland S. Supporting immunization programs with improved vaccine cold chain information systems. InIEEE global humanitarian technology conference (GHTC 2014) 2014 Oct 10 (pp. 215-222). IEEE.
  10. Bremer P. Towards a reference model for the cold chain. The International Journal of Logistics Management. 2018 Aug 17;29(3):822-38.
  11. Weiss WM, Winch PJ, Burnham G. Factors associated with missed vaccination during mass immunization campaigns. Journal of health, population, and nutrition. 2009 Jun;27(3):358.
  12. Bonu S, Rani M, Baker TD. The impact of the national polio immunization campaign on levels and equity in immunization coverage: evidence from rural North India. Social science & medicine. 2003 Nov 1;57(10):1807-19.
  13. Duintjer Tebbens RJ, Kalkowska DA, Wassilak SG, Pallansch MA, Cochi SL, Thompson KM. The potential impact of expanding target age groups for polio immunization campaigns. BMC Infectious Diseases. 2014 Dec;14:1-7.
Ahead of Print Subscription Review Article
Volume
Received May 16, 2024
Accepted July 9, 2024
Published July 18, 2024
Views: 27